Seguir
Kelly R. Rhodes
Kelly R. Rhodes
Dirección de correo verificada de jhmi.edu
Título
Citado por
Citado por
Año
Noninvasive targeted transcranial neuromodulation via focused ultrasound gated drug release from nanoemulsions
RD Airan, RA Meyer, NPK Ellens, KR Rhodes, K Farahani, MG Pomper, ...
Nano letters 17 (2), 652-659, 2017
1692017
Poly (beta-amino ester) s as gene delivery vehicles: challenges and opportunities
J Karlsson, KR Rhodes, JJ Green, SY Tzeng
Expert opinion on drug delivery 17 (10), 1395-1410, 2020
812020
Nanoscale artificial antigen presenting cells for cancer immunotherapy
KR Rhodes, JJ Green
Molecular immunology 98, 13-18, 2018
742018
Polymeric micro-and nanoparticles for immune modulation
E Ben-Akiva, SE Witte, RA Meyer, KR Rhodes, JJ Green
Biomaterials science 7 (1), 14-30, 2019
722019
Development of a 3D printed, bioengineered placenta model to evaluate the role of trophoblast migration in preeclampsia
CY Kuo, A Eranki, JK Placone, KR Rhodes, H Aranda-Espinoza, ...
ACS Biomaterials Science & Engineering 2 (10), 1817-1826, 2016
722016
In situ genetic engineering of tumors for long-lasting and systemic immunotherapy
SY Tzeng, KK Patel, DR Wilson, RA Meyer, KR Rhodes, JJ Green
Proceedings of the National Academy of Sciences 117 (8), 4043-4052, 2020
392020
Biodegradable cationic polymer blends for fabrication of enhanced artificial antigen presenting cells to treat melanoma
KR Rhodes, A Isser, JW Hickey, E Ben-Akiva, RA Meyer, AK Kosmides, ...
ACS applied materials & interfaces 13 (7), 7913-7923, 2021
242021
Biomimetic tolerogenic artificial antigen presenting cells for regulatory T cell induction
KR Rhodes, RA Meyer, J Wang, SY Tzeng, JJ Green
Acta biomaterialia 112, 136-148, 2020
232020
Bioengineered particles expand myelin-specific regulatory T cells and reverse autoreactivity in a mouse model of multiple sclerosis
KR Rhodes, SY Tzeng, M Iglesias, D Lee, K Storm, SY Neshat, ...
Science Advances 9 (22), eadd8693, 2023
102023
Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy
E Ben-Akiva, JW Hickey, RA Meyer, A Isser, SR Shannon, NK Livingston, ...
Acta Biomaterialia 160, 187-197, 2023
82023
Wear particles derived from metal hip implants induce the generation of multinucleated giant cells in a 3-dimensional peripheral tissue-equivalent model
DK Dutta, PA Potnis, K Rhodes, SC Wood
Plos one 10 (4), e0124389, 2015
82015
Improvement of islet engrafts via Treg induction using immunomodulating polymeric tolerogenic microparticles
SY Neshat, SJ Bauer, KR Rhodes, VM Quiroz, VW Wong, SM Lowmaster, ...
ACS Biomaterials Science & Engineering 9 (6), 3522-3534, 2023
52023
Fabrication of anisotropic polymeric artificial antigen presenting cells for CD8+ T cell activation
E Ben-Akiva, KR Rhodes, RA Meyer, JJ Green
JoVE (Journal of Visualized Experiments), e58332, 2018
52018
In silico prediction of Ebola Zaire GP1,2 immuno-dominant epitopes for the Balb/c mouse
DK Dutta, K Rhodes, SC Wood
BMC immunology 16, 1-10, 2015
52015
Development of a 3D Printed, Bioengineered Placenta Model to Evaluate the Role of Trophoblast Migration in Preeclampsia. ACS Biomaterials Science & Engineering. 2016
CY Kuo, A Eranki, JK Placone, KR Rhodes, H Aranda-Espinoza, ...
42016
PLoS One
DK Dutta, PA Potnis, K Rhodes, SC Wood
32014
Tolerogenic Artificial Antigen Presenting Cells for Selective Tolerance in Autoimmune Disease
G Raimondi, K Rhodes, S Tzeng, MI Lozano, D VanDyke, S Neshat, ...
The Journal of Immunology 208 (1_Supplement), 60.18-60.18, 2022
12022
Automated Bioprinting of Customized Tissue Engineered Grafts for Tympanic Membrane Perforation Repair
C Kuo, E Wilson, K Rhodes, A Fuson, J Fisher, K Cleary, B Reilly
TISSUE ENGINEERING PART A 22, S29-S29, 2016
12016
Particle elasticity influences polymeric artificial antigen presenting cell effectiveness in vivo via CD8+ T cell activation, macrophage uptake, and the protein corona
SE Est-Witte, SR Shannon, DH Gong, KG Calabresi, JJ Harris, K Storm, ...
Nano Research, 1-13, 2024
2024
POLYMERIC PARTICLE-BASED DRUG DELIVERY PLATFORMS FOR IMMUNE MODULATION
K Rhodes
Johns Hopkins University, 2022
2022
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20